Stromal FAP is an independent poor prognosis marker in non-small cell lung adenocarcinoma and associated with p53 mutation.
暂无分享,去创建一个
C. Klein | P. Micke | J. Botling | A. Östman | A. Mezheyeuski | Sara Corvigno | C. Strell | M. Backman | N. T. Te Grootenhuis | Pablo Moreno-Ruiz | G. Hoelzlwimmer | L. La Fleur | N. T. te Grootenhuis